Friday, May 16, 2025

Portugal Approves Esketamine for Severe Depression Treatment

Portugal has taken a significant step in mental health care by approving public funding for esketamine, a psychedelic drug used to treat severe depression. This decision, announced by Infarmed, the National...
Latest
Recommended

Portugal Approves Esketamine for Severe Depression Treatment

Portugal has taken a significant step in mental health care by approving public funding for esketamine, a psychedelic drug used to treat severe depression. This decision, announced by Infarmed,...

Psilocybin-Assisted Therapy Shows Promise for Substance Use Disorders

A recent scientific review has examined the potential of psilocybin-assisted therapy (PAP) as a treatment for substance use disorders (SUDs), focusing on its impact on alcohol, tobacco, and opioid...

Portugal Approves Esketamine for Severe Depression Treatment

Portugal has taken a significant step in mental health care by approving public funding for esketamine, a psychedelic drug used to treat severe depression. This decision, announced by Infarmed, the National...

Psilocybin-Assisted Therapy Shows Promise for Substance Use Disorders

A recent scientific review has examined the potential of psilocybin-assisted therapy (PAP) as a treatment for substance use disorders (SUDs), focusing on its impact...

Psychedelics May Disrupt Immune-Driven Fear Responses, Offering New Hope for Mental Health Treatment

A groundbreaking study from Mass General Brigham has unveiled a previously unknown connection between the immune system and the brain's fear response. The research...

Join our community of SUBSCRIBERS and be part of the conversation.

To subscribe, simply enter your email address on our website or click the subscribe button below. Don't worry, we respect your privacy and won't spam your inbox. Your information is safe with us.